Target Price | $35.76 |
Price | $29.54 |
Potential | 21.06% |
Number of Estimates | 25 |
25 Analysts have issued a price target CSX 2026 . The average CSX target price is $35.76. This is 21.06% higher than the current stock price. The highest price target is $42.00 42.18% , the lowest is $28.00 5.21% . | |
A rating was issued by 30 analysts: 20 Analysts recommend CSX to buy, 10 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the CSX stock has an average upside potential 2026 of 21.06% . Most analysts recommend the CSX stock at Purchase. |
21 Analysts have issued a sales forecast CSX 2025 . The average CSX sales estimate is $14.6b . This is 0.54% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $14.9b 2.21% , the lowest is $14.1b 3.00% .
This results in the following potential growth metrics:
2024 | $14.5b | 0.80% |
---|---|---|
2025 | $14.6b | 0.54% |
2026 | $15.3b | 4.98% |
2027 | $15.8b | 3.22% |
2028 | $16.9b | 6.38% |
2029 | $17.7b | 5.18% |
22 Analysts have issued an CSX EBITDA forecast 2025. The average CSX EBITDA estimate is $7.0b . This is 0.71% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $7.2b 2.71% , the lowest is $6.7b 4.38% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $7.1b | 0.72% |
---|---|---|
2025 | $7.0b | 1.31% |
2026 | $7.5b | 8.19% |
2027 | $7.8b | 4.03% |
2028 | $8.3b | 5.39% |
2029 | $8.8b | 6.41% |
2024 | 48.50% | 0.08% |
---|---|---|
2025 | 47.60% | 1.86% |
2026 | 49.06% | 3.07% |
2027 | 49.44% | 0.77% |
2028 | 48.98% | 0.93% |
2029 | 49.56% | 1.18% |
16 CSX Analysts have issued a net profit forecast 2025. The average CSX net profit estimate is $3.5b . This is 1.71% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $3.7b 7.69% , the lowest is $3.2b 4.47% .
This results in the following potential growth metrics and future Net Margins:
2024 | $3.4b | 1.65% |
---|---|---|
2025 | $3.5b | 1.71% |
2026 | $4.0b | 15.43% |
2027 | $4.3b | 6.50% |
2028 | $4.8b | 12.36% |
2029 | $5.4b | 12.03% |
2024 | 23.39% | 0.86% |
---|---|---|
2025 | 23.66% | 1.14% |
2026 | 26.02% | 9.97% |
2027 | 26.85% | 3.19% |
2028 | 28.36% | 5.62% |
2029 | 30.20% | 6.49% |
16 Analysts have issued a CSX forecast for earnings per share. The average CSX EPS is $1.82 . This is 1.68% higher than earnings per share in the financial year 2024. The highest EPS forecast is $1.93 7.82% , the lowest is $1.71 4.47% .
This results in the following potential growth metrics and future valuations:
2024 | $1.79 | 1.65% |
---|---|---|
2025 | $1.82 | 1.68% |
2026 | $2.10 | 15.38% |
2027 | $2.24 | 6.67% |
2028 | $2.51 | 12.05% |
2029 | $2.82 | 12.35% |
Current | 16.49 | 17.96% |
---|---|---|
2025 | 16.23 | 1.58% |
2026 | 14.06 | 13.37% |
2027 | 13.20 | 6.12% |
2028 | 11.75 | 10.98% |
2029 | 10.49 | 10.72% |
Based on analysts' sales estimates for 2025, the CSX stock is valued at an EV/Sales of 5.06 and an P/S ratio of 3.83 .
This results in the following potential growth metrics and future valuations:
Current | 5.09 | 17.37% |
---|---|---|
2025 | 5.06 | 0.51% |
2026 | 4.82 | 4.75% |
2027 | 4.67 | 3.12% |
2028 | 4.39 | 6.00% |
2029 | 4.18 | 4.93% |
Current | 3.85 | 22.32% |
---|---|---|
2025 | 3.83 | 0.54% |
2026 | 3.65 | 4.75% |
2027 | 3.53 | 3.12% |
2028 | 3.32 | 6.00% |
2029 | 3.16 | 4.93% |
Analyst | Rating | Action | Date |
---|---|---|---|
Susquehanna |
Positive
➜
Positive
|
Unchanged | Mar 27 2025 |
Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Mar 27 2025 |
Loop Capital |
Buy
➜
Hold
|
Downgrade | Feb 03 2025 |
Benchmark |
Buy
➜
Buy
|
Unchanged | Jan 27 2025 |
Baird |
Outperform
➜
Outperform
|
Unchanged | Jan 24 2025 |
JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Jan 24 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | Jan 24 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Susquehanna:
Positive
➜
Positive
|
Mar 27 2025 |
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Mar 27 2025 |
Downgrade
Loop Capital:
Buy
➜
Hold
|
Feb 03 2025 |
Unchanged
Benchmark:
Buy
➜
Buy
|
Jan 27 2025 |
Unchanged
Baird:
Outperform
➜
Outperform
|
Jan 24 2025 |
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Jan 24 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
Jan 24 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.